{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:15:38Z","timestamp":1793153738570,"version":"4.5.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T00:00:00Z","timestamp":1687392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T00:00:00Z","timestamp":1687392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s40265-023-01906-4","type":"journal-article","created":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T06:43:18Z","timestamp":1687502598000},"page":"1067-1076","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Pharmacologic Management of Cancer-Related Pain in Pregnant Patients"],"prefix":"10.1007","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3274-6678","authenticated-orcid":false,"given":"Isabelle","family":"Zerfas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reagan","family":"McGinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9762-0104","authenticated-orcid":false,"given":"Michael A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,22]]},"reference":[{"issue":"1","key":"1906_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.14740\/wjon1177","volume":"10","author":"A Hepner","year":"2019","unstructured":"Hepner A, Negrini D, Hase EA, Exman P, Testa L, Trinconi AF, Filassi JR, Francisco RPV, Zugaib M, O\u2019Connor TL, Martin MG. Cancer during pregnancy: the oncologist overview. World J Oncol. 2019;10(1):28\u201334.","journal-title":"World J Oncol"},{"issue":"1","key":"1906_CR2","first-page":"1","volume":"72","author":"MJK Osterman","year":"2023","unstructured":"Osterman MJK, Hamilton BE, Martin JA, Driscoll AK, Valenzuela CP. Births: final data for 2021. National Vital Statistics Report. 2023;72(1):1\u201354.","journal-title":"National Vital Statistics Report"},{"issue":"2","key":"1906_CR3","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1055\/s-0040-1714394","volume":"39","author":"KK Ma","year":"2022","unstructured":"Ma KK, Monsell SE, Chandrasekaran S, Gadi VK, Gammill HS. Cancer and pregnancy: national trends. Am J Perinatol. 2022;39(2):144\u201353.","journal-title":"Am J Perinatol"},{"key":"1906_CR4","doi-asserted-by":"crossref","unstructured":"Higginson IJ, Murtagh FE, Osborne TR. Epidemiology of pain in cancer. Cancer Pain; 2013. p. 5\u201324.","DOI":"10.1007\/978-0-85729-230-8_2"},{"issue":"9","key":"1906_CR5","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/annonc\/mdm056","volume":"18","author":"MH van den Beuken-van Everdingen","year":"2007","unstructured":"van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007;18(9):1437\u201349.","journal-title":"Ann Oncol"},{"issue":"2","key":"1906_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0263527","volume":"17","author":"Y Lin","year":"2022","unstructured":"Lin Y, De Araujo I, Stanley G, Small D, Geha P. Chronic pain precedes disrupted eating behavior in low-back pain patients. PLoS\u00a0One. 2022;17(2): e0263527.","journal-title":"PLoS\u00a0One"},{"issue":"6","key":"1906_CR7","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/HRP.0000000000000198","volume":"26","author":"WW Ishak","year":"2018","unstructured":"Ishak WW, Wen RY, Naghdechi L, Vanle B, Dang J, Knosp M, Dascal J, Marcia L, Gohar Y, Eskander L, Yadegar J, Hanna S, Sadek A, Aguilar-Hernandez L, Danovitch I, Louy C. Pain and depression: a systematic review. Harv Rev Psychiatry. 2018;26(6):352\u201363.","journal-title":"Harv Rev Psychiatry"},{"issue":"8","key":"1906_CR8","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/jch.12145","volume":"15","author":"M Sacc\u00f2","year":"2013","unstructured":"Sacc\u00f2 M, Meschi M, Regolisti G, Detrenis S, Bianchi L, Bertorelli M, Pioli S, Magnano A, Spagnoli F, Giuri PG, Fiaccadori E, Caiazza A. The relationship between blood pressure and pain. J Clin Hypertens (Greenwich). 2013;15(8):600\u20135.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"1906_CR9","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4217593","volume":"2022","author":"T Chen","year":"2022","unstructured":"Chen T, Wang J, Wang YQ, Chu YX. Current understanding of the neural circuitry in the comorbidity of chronic pain and anxiety. Neural Plast. 2022;2022: 4217593.","journal-title":"Neural Plast"},{"issue":"5","key":"1906_CR10","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1097\/AOG.0000000000004057","volume":"136","author":"CC Brown","year":"2020","unstructured":"Brown CC, Adams CE, George KE, Moore JE. Associations between comorbidities and severe maternal morbidity. Obstet Gynecol. 2020;136(5):892\u2013901.","journal-title":"Obstet Gynecol"},{"issue":"8","key":"1906_CR11","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJMoa1000678","volume":"363","author":"JS Temel","year":"2010","unstructured":"Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733\u201342.","journal-title":"N Engl J Med"},{"issue":"9930","key":"1906_CR12","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/S0140-6736(13)62416-2","volume":"383","author":"C Zimmermann","year":"2014","unstructured":"Zimmermann C, Swami N, Krzyzanowska M, Hannon B, Leighl N, Oza A, Moore M, Rydall A, Rodin G, Tannock I, Donner A, Lo C. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet. 2014;383(9930):1721\u201330.","journal-title":"Lancet"},{"key":"1906_CR13","unstructured":"Swarm RA, Youngwerth JM, Ange JL, Anghelescu DL, Are M, Buga S, Chwistek M, Copenhaver D, Craig D, Finnes H, Greenlee H, Hansen E, Kamal AH, Kamdar MM, Kandil E, Mackey S, McDonald A, McDowell MR, McGrath K, Moryl N, Nesbit S, Paice JA, Phung P, Prsic E, Rabow MW, Rickerson E, Shatsky R, Sindt J, Smith M, Bruce JY. NCCN clinical practice guidelines in oncology: adult cancer pain. Version 2; 2022. NCCN.org [Accessed 2023 January 7]."},{"issue":"11","key":"1906_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002160","volume":"13","author":"G Pariente","year":"2016","unstructured":"Pariente G, Leibson T, Carls A, Adams-Webber T, Ito S, Koren G. Pregnancy-associated changes in pharmacokinetics: a systematic review. PLoS Med. 2016;13(11): e1002160.","journal-title":"PLoS Med"},{"issue":"4","key":"1906_CR15","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3390\/cancers11040510","volume":"11","author":"A Caraceni","year":"2019","unstructured":"Caraceni A, Shkodra M. Cancer-related pain assessment and classification. Cancers (Basel). 2019;11(4):510.","journal-title":"Cancers (Basel)"},{"issue":"8","key":"1906_CR16","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1007\/s00520-019-04825-x","volume":"27","author":"C Minello","year":"2019","unstructured":"Minello C, George B, Allano G, Maindet C, Burnod A, Lemaire A. Assessing cancer pain-the first step toward improving patients\u2019 quality of life. Support Care Cancer. 2019;27(8):3095\u2013104.","journal-title":"Support Care Cancer"},{"key":"1906_CR17","unstructured":"Boyd D, Butler M, Carr D, et\u00a0al. Terminology. In: International Association for the Study of Pain (IASP); 2022. iasp-pain.org [Accessed 1 Feb 2023]."},{"issue":"15","key":"1906_CR18","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.3390\/jcm10153203","volume":"10","author":"J Nijs","year":"2021","unstructured":"Nijs J, Lahousse A, Kapreli E, Bilika P, Sara\u00e7o\u011flu \u0130, Malfliet A, Coppieters I, De Baets L, Leysen L, Roose E, Clark J, Voogt L, Huysmans E. Nociplastic pain criteria or recognition of central sensitization? Pain phenotyping in the past, present and future. J Clin Med. 2021;10(15):3203.","journal-title":"J Clin Med"},{"issue":"2","key":"1906_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/jabr.12137","volume":"23","author":"SE Harte","year":"2018","unstructured":"Harte SE, Harris RE, Clauw DJ. The neurobiology of central sensitization. J Appl Biobehav Res. 2018;23(2): e12137.","journal-title":"J Appl Biobehav Res"},{"issue":"10289","key":"1906_CR20","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1016\/S0140-6736(21)00392-5","volume":"397","author":"MA Fitzcharles","year":"2021","unstructured":"Fitzcharles MA, Cohen SP, Clauw DJ, Littlejohn G, Usui C, H\u00e4user W. Nociplastic pain: towards an understanding of prevalent pain conditions. Lancet. 2021;397(10289):2098\u2013110.","journal-title":"Lancet"},{"issue":"1","key":"1906_CR21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/humupd\/dmaa042","volume":"27","author":"A Zafeiri","year":"2021","unstructured":"Zafeiri A, Mitchell RT, Hay DC, Fowler PA. Over-the-counter analgesics during pregnancy: a comprehensive review of global prevalence and offspring safety. Hum Reprod Update. 2021;27(1):67\u201395.","journal-title":"Hum Reprod Update"},{"issue":"21","key":"1906_CR22","doi-asserted-by":"publisher","first-page":"13926","DOI":"10.1073\/pnas.162468699","volume":"99","author":"NV Chandrasekharan","year":"2002","unstructured":"Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS, Simmons DL. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic\/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA. 2002;99(21):13926\u201331.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"1906_CR23","first-page":"2517","volume":"67","author":"RA Black","year":"2003","unstructured":"Black RA, Hill DA. Over-the-counter medications in pregnancy. Am Fam Physician. 2003;67(12):2517\u201324.","journal-title":"Am Fam Physician"},{"issue":"4","key":"1906_CR24","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1001\/jamapediatrics.2013.4914","volume":"168","author":"Z Liew","year":"2014","unstructured":"Liew Z, Ritz B, Rebordosa C, Lee PC, Olsen J. Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders. JAMA Pediatr. 2014;168(4):313\u201320.","journal-title":"JAMA Pediatr"},{"key":"1906_CR25","doi-asserted-by":"crossref","unstructured":"Thompson JM, Waldie KE, Wall CR, Murphy R, Mitchell EA. Associations between acetaminophen use during pregnancy and ADHD symptoms measured at ages 7 and 11 years. PLoS One. 2014;9(9):e108210.","DOI":"10.1371\/journal.pone.0108210"},{"issue":"8","key":"1906_CR26","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1093\/aje\/kwy086","volume":"187","author":"R Masarwa","year":"2018","unstructured":"Masarwa R, Levine H, Gorelik E, Reif S, Perlman A, Matok I. Prenatal exposure to acetaminophen and risk for attention deficit hyperactivity disorder and autistic spectrum disorder: a systematic review, meta-analysis, and meta-regression analysis of cohort studies. Am J Epidemiol. 2018;187(8):1817\u201327.","journal-title":"Am J Epidemiol"},{"issue":"3","key":"1906_CR27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1177\/0004867418823276","volume":"53","author":"X Gou","year":"2019","unstructured":"Gou X, Wang Y, Tang Y, Qu Y, Tang J, Shi J, Xiao D, Mu D. Association of maternal prenatal acetaminophen use with the risk of attention deficit\/hyperactivity disorder in offspring: a meta-analysis. Aust N Z J Psychiatry. 2019;53(3):195\u2013206.","journal-title":"Aust N Z J Psychiatry"},{"issue":"1","key":"1906_CR28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2174\/187152312803476255","volume":"11","author":"S Bacchi","year":"2012","unstructured":"Bacchi S, Palumbo P, Sponta A, Coppolino MF. Clinical pharmacology of non-steroidal anti-inflammatory drugs: a review. Antiinflamm Antiallergy Agents Med Chem. 2012;11(1):52\u201364.","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"key":"1906_CR29","unstructured":"Drug Safety Communication. FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later because they can result in low amniotic fluid. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-recommends-avoiding-use-nsaids-pregnancy-20-weeks-or-later-because-they-can-result-low-amniotic. Accessed June 2, 2023."},{"key":"1906_CR30","doi-asserted-by":"crossref","unstructured":"Dathe K, Frank J, Padberg S, Hultzsch S, Beck E, Schaefer C. Fetal adverse effects following NSAID or metamizole exposure in the 2nd and 3rd trimester: an evaluation of the German Embryotox cohort. BMC Pregnancy Childbirth. 2022;22(1):666.","DOI":"10.1186\/s12884-022-04986-4"},{"issue":"2","key":"1906_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004183","volume":"20","author":"EY Choi","year":"2023","unstructured":"Choi EY, Jeong HE, Noh Y, Choi A, Yon DK, Han JY, Sung JH, Choe SA, Shin JY. Neonatal and maternal adverse outcomes and exposure to nonsteroidal anti-inflammatory drugs during early pregnancy in South Korea: a nationwide cohort study. PLoS Med. 2023;20(2): e1004183.","journal-title":"PLoS Med"},{"key":"1906_CR32","doi-asserted-by":"crossref","unstructured":"Haywood A, Good P, Khan S, Leupp A, Jenkins-Marsh S, Rickett K, Hardy JR. Corticosteroids for the management of cancer-related pain in adults. Cochrane Database Syst Rev. 2015;2015(4):CD010756.","DOI":"10.1002\/14651858.CD010756.pub2"},{"issue":"2","key":"1906_CR33","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/SPC.0000000000000263","volume":"11","author":"FMY Lim","year":"2017","unstructured":"Lim FMY, Bobrowski A, Agarwal A, Silva MF. Use of corticosteroids for pain control in patients with bone metastases: a comprehensive literature review. Curr Opin Support Palliat Care. 2017;11(2):78\u201387.","journal-title":"Curr Opin Support Palliat Care"},{"issue":"1","key":"1906_CR34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1177\/1049909116683720","volume":"35","author":"P White","year":"2018","unstructured":"White P, Arnold R, Bull J, Cicero B. The use of corticosteroids as adjuvant therapy for painful bone metastases: a large cross-sectional survey of palliative care providers. Am J Hosp Palliat Care. 2018;35(1):151\u20138.","journal-title":"Am J Hosp Palliat Care"},{"issue":"4","key":"1906_CR35","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11916-012-0273-z","volume":"16","author":"W Leppert","year":"2012","unstructured":"Leppert W, Buss T. The role of corticosteroids in the treatment of pain in cancer patients. Curr Pain Headache Rep. 2012;16(4):307\u201313.","journal-title":"Curr Pain Headache Rep"},{"key":"1906_CR36","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.reprotox.2011.05.023","volume":"32","author":"RE Rocklin","year":"2011","unstructured":"Rocklin RE. Asthma, asthma medications and their effects on maternal\/fetal outcomes during pregnancy. Reprod Toxicol. 2011;32:189\u201397.","journal-title":"Reprod Toxicol"},{"issue":"1","key":"1906_CR37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.placenta.2005.12.010","volume":"28","author":"VE Murphy","year":"2007","unstructured":"Murphy VE, Fittock RJ, Zarzycki PK, Delahunty MM, Smith R, Clifton VL. Metabolism of synthetic steroids by the human placenta. Placenta. 2007;28(1):39\u201346.","journal-title":"Placenta"},{"issue":"3","key":"1906_CR38","doi-asserted-by":"publisher","first-page":"160","DOI":"10.4274\/jcrpe.v3i3.31","volume":"3","author":"S Kurtoglu","year":"2011","unstructured":"Kurtoglu S, Sarici D, Akin MA, Daar G, Korkmaz L, Memur S. Fetal adrenal suppression due to maternal corticosteroid use: case report. J Clin Res Pediatr Endocrinol. 2011;3(3):160\u20132.","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"1906_CR39","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1080\/02841860500401167","volume":"45","author":"SH Lundstr\u00f6m","year":"2006","unstructured":"Lundstr\u00f6m SH, Furst CJ. The use of corticosteroids in Swedish palliative care. Acta Oncol. 2006;45:430\u20137.","journal-title":"Acta Oncol"},{"issue":"2","key":"1906_CR40","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1177\/1049909118797283","volume":"36","author":"LR Jaward","year":"2019","unstructured":"Jaward LR, O\u2019Neil TA, Marks A, Smith MA. Differences in adverse effect profiles of corticosteroids in palliative care patients. Am J Hosp Palliat Care. 2019;36(2):158\u201368.","journal-title":"Am J Hosp Palliat Care"},{"key":"1906_CR41","doi-asserted-by":"crossref","unstructured":"HAPO Study Cooperative Research Group; Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991\u20132002.","DOI":"10.1056\/NEJMoa0707943"},{"issue":"4","key":"1906_CR42","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/art.41191","volume":"72","author":"LR Sammaritano","year":"2020","unstructured":"Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, Marder W, Guyatt G, Branch DW, Buyon J, Christopher-Stine L, Crow-Hercher R, Cush J, Druzin M, Kavanaugh A, Laskin CA, Plante L, Salmon J, Simard J, Somers EC, Steen V, Tedeschi SK, Vinet E, White CW, Yazdany J, Barbhaiya M, Bettendorf B, Eudy A, Jayatilleke A, Shah AA, Sullivan N, Tarter LL, BirruTalabi M, Turgunbaev M, Turner A, D\u2019Anci KE. 2020 American College of Rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases. Arthritis Rheumatol. 2020;72(4):529\u201356.","journal-title":"Arthritis Rheumatol"},{"key":"1906_CR43","doi-asserted-by":"crossref","unstructured":"Bruera E, Paice JA. Cancer-related pain management: safe and effective use of opioids. Am Soc Clin Oncol Educ Book. 2015:e593\u20139.","DOI":"10.14694\/EdBook_AM.2015.35.e593"},{"key":"1906_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.108045","volume":"234","author":"MW van Hoogdalem","year":"2022","unstructured":"van Hoogdalem MW, Wexelblatt SL, Akinbi HT, Vinks AA, Mizuno T. A review of pregnancy-induced changes in opioid pharmacokinetics, placental transfer, and fetal exposure: towards fetomaternal physiologically-based pharmacokinetic modeling to improve the treatment of neonatal opioid withdrawal syndrome. Pharmacol Ther. 2022;234: 108045.","journal-title":"Pharmacol Ther"},{"issue":"5","key":"1906_CR45","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1097\/ALN.0000000000000172","volume":"120","author":"BT Bateman","year":"2014","unstructured":"Bateman BT, Hernandez-Diaz S, Rathmell JP, Seeger JD, Doherty M, Fischer MA, Huybrechts KF. Patterns of opioid utilization in pregnancy in a large cohort of commercial insurance beneficiaries in the United States. Anesthesiology. 2014;120(5):1216\u201324.","journal-title":"Anesthesiology"},{"key":"1906_CR46","doi-asserted-by":"crossref","unstructured":"Ko JY, D\u2019Angelo DV, Haight SC, et\u00a0al. Vital signs: prescription opioid pain reliever use during pregnancy\u201434 U.S. Jurisdictions, 2019. MMWR Morb Mortal Wkly Rep. 2020;69:897\u2013903.","DOI":"10.15585\/mmwr.mm6928a1"},{"issue":"314","key":"1906_CR47","first-page":"e1","volume":"204","author":"CS Broussard","year":"2011","unstructured":"Broussard CS, Rasmussen SA, Reefhuis J, Friedman JM, Jann MW, Riehle-Colarusso T, Honein MA. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol. 2011;204(314):e1\u201311.","journal-title":"Am J Obstet Gynecol"},{"key":"1906_CR48","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1097\/AOG.0b013e3182a6643c","volume":"122","author":"MM Yazdy","year":"2013","unstructured":"Yazdy MM, Mitchell AA, Tinker SC, Parker SE, Werler MM. Periconceptional use of opioids and the risk of neural tube defects. Obstet Gynecol. 2013;122:838\u201344.","journal-title":"Obstet Gynecol"},{"key":"1906_CR49","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s00228-011-1069-5","volume":"67","author":"K Nezvalova-Henriksen","year":"2011","unstructured":"Nezvalova-Henriksen K, Spigset O, Nordeng H. Effects of codeine on pregnancy outcome: results from a large population-based cohort study. Eur J Clin Pharmacol. 2011;67:1253\u201361.","journal-title":"Eur J Clin Pharmacol"},{"key":"1906_CR50","doi-asserted-by":"crossref","unstructured":"The ASAM national practice guideline for the treatment of opioid use disorder: 2020 focused update. J Addict Med. 2020;14(2S Suppl 1):1\u201391 (Erratum in: J Addict Med. 2020;14(3):267).","DOI":"10.1097\/ADM.0000000000000633"},{"issue":"1","key":"1906_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2004.11.013","volume":"79","author":"HE Jones","year":"2005","unstructured":"Jones HE, Johnson RE, Jasinski DR, O\u2019Grady KE, Chisholm CA, Choo RE, Crocetti M, Dudas R, Harrow C, Huestis MA, Jansson LM, Lantz M, Lester BM, Milio L. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend. 2005;79(1):1\u201310.","journal-title":"Drug Alcohol Depend"},{"issue":"24","key":"1906_CR52","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","volume":"363","author":"HE Jones","year":"2010","unstructured":"Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, O\u2019Grady KE, Selby P, Martin PR, Fischer G. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 2010;363(24):2320\u201331.","journal-title":"N Engl J Med"},{"issue":"4","key":"1906_CR53","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/J354v19n04_05","volume":"19","author":"RA Lugo","year":"2005","unstructured":"Lugo RA, Satterfield KL, Kern SE. Pharmacokinetics of methadone. J Pain Palliat Care Pharmacother. 2005;19(4):13\u201324.","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"1906_CR54","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/AJP.0b013e31815ca2b4","volume":"24","author":"HA Heit","year":"2008","unstructured":"Heit HA, Gourlay DL. Buprenorphine: new tricks with an old molecule for pain management. Clin J Pain. 2008;24:93\u20137.","journal-title":"Clin J Pain"},{"key":"1906_CR55","doi-asserted-by":"crossref","unstructured":"Schmidt-Hansen M, Bromham N, Taubert M, Arnold S, Hilgart JS. Buprenorphine for treating cancer-related pain. Cochrane Database Syst Rev. 2015;2015(3):CD009596.","DOI":"10.1002\/14651858.CD003870.pub5"},{"issue":"5","key":"1906_CR56","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1177\/1049909119884358","volume":"37","author":"E Hansen","year":"2020","unstructured":"Hansen E, Nadagoundla C, Wang C, Miller A, Case AA. Buprenorphine for cancer-related pain in patients with nonmedical opioid use: a retrospective study at a comprehensive cancer center. Am J Hosp Palliat Care. 2020;37(5):350\u20133.","journal-title":"Am J Hosp Palliat Care"},{"issue":"Suppl 1","key":"1906_CR57","doi-asserted-by":"publisher","first-page":"s25","DOI":"10.1191\/0269216306pm1125oa","volume":"20","author":"R Sittl","year":"2006","unstructured":"Sittl R. Transdermal buprenorphine in cancer-related pain and palliative care. Palliat Med. 2006;20(Suppl 1):s25\u201330.","journal-title":"Palliat Med"},{"issue":"8","key":"1906_CR58","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1089\/jpm.2020.0524","volume":"24","author":"M Irwin","year":"2021","unstructured":"Irwin M, Petersen KS, Smith MA. Rapid buprenorphine induction for cancer-related pain in pregnancy. J Palliat Med. 2021;24(8):1257\u201362.","journal-title":"J Palliat Med"},{"key":"1906_CR59","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ajog.2016.10.003","volume":"216","author":"JJ McCarthy","year":"2017","unstructured":"McCarthy JJ, Leamon MH, Finnegan LP, Fassbender C. Opioid dependence and pregnancy: minimizing stress on the fetal brain. Am J Obstet Gynecol. 2017;216:226\u201331.","journal-title":"Am J Obstet Gynecol"},{"key":"1906_CR60","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3109\/14767058.2011.600371","volume":"25","author":"JJ McCarthy","year":"2012","unstructured":"McCarthy JJ. Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus? J Matern Neonatal Med. 2012;25:109\u201312.","journal-title":"J Matern Neonatal Med"},{"issue":"5","key":"1906_CR61","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1080\/17425255.2020.1750598","volume":"16","author":"G Schoretsanitis","year":"2020","unstructured":"Schoretsanitis G, Spigset O, Stingl JC, Deligiannidis KM, Paulzen M, Westin AA. The impact of pregnancy on the pharmacokinetics of antidepressants: a systematic critical review and meta-analysis. Expert Opin Drug Metab Toxicol. 2020;16(5):431\u201340.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"6","key":"1906_CR62","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.3904\/kjim.2018.162","volume":"33","author":"SY Yoon","year":"2018","unstructured":"Yoon SY, Oh J. Neuropathic cancer-related pain: prevalence, pathophysiology, and management. Korean J Intern Med. 2018;33(6):1058\u201369.","journal-title":"Korean J Intern Med"},{"issue":"3\u20134","key":"1906_CR63","first-page":"37","volume":"11","author":"RA Sansone","year":"2014","unstructured":"Sansone RA, Sansone LA. Serotonin norepinephrine reuptake inhibitors: a pharmacological comparison. Innov Clin Neurosci. 2014;11(3\u20134):37\u201342.","journal-title":"Innov Clin Neurosci"},{"key":"1906_CR64","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m237","volume":"368","author":"KF Huybrechts","year":"2020","unstructured":"Huybrechts KF, Bateman BT, Pawar A, Bessette LG, Mogun H, Levin R, Li H, Motsko S, Scantamburlo Fernandes MF, Upadhyaya HP, Hernandez-Diaz S. Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study. BMJ. 2020;368: m237.","journal-title":"BMJ"},{"key":"1906_CR65","unstructured":"Venlafaxine: more dangerous than most \u201cselective\u201d serotonergic antidepressants. Prescrire Int. 2016;25(170):96\u20139."},{"key":"1906_CR66","doi-asserted-by":"crossref","unstructured":"Polen KN, Rasmussen SA, Riehle-Colarusso T, Reefhuis J; National Birth Defects Prevention Study. Association between reported venlafaxine use in early pregnancy and birth defects, national birth defects prevention study, 1997\u20132007. Birth Defects Res A Clin Mol Teratol. 2013;97(1):28\u201335.","DOI":"10.1002\/bdra.23096"},{"issue":"1","key":"1906_CR67","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/bdrb.20144","volume":"83","author":"TF Oberlander","year":"2008","unstructured":"Oberlander TF, Warburton W, Misri S, Riggs W, Aghajanian J, Hertzman C. Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data. Birth Defects Res (Part B). 2008;83(1):68\u201376.","journal-title":"Birth Defects Res (Part B)"},{"key":"1906_CR68","doi-asserted-by":"crossref","unstructured":"Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ. Amitriptyline for neuropathic pain in adults. Cochrane Database Syst Rev. 2015;2015(7):CD008242.","DOI":"10.1002\/14651858.CD011605"},{"key":"1906_CR69","doi-asserted-by":"crossref","unstructured":"Derry S, Wiffen PJ, Aldington D, Moore RA. Nortriptyline for neuropathic pain in adults. Cochrane Database Syst Rev. 2015;1(1):CD011209.","DOI":"10.1002\/14651858.CD011669"},{"issue":"3","key":"1906_CR70","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/1049909111412539","volume":"29","author":"S Mishra","year":"2012","unstructured":"Mishra S, Bhatnagar S, Goyal GN, Rana SP, Upadhya SP. A comparative efficacy of amitriptyline, gabapentin, and pregabalin in neuropathic cancer pain: a prospective randomized double-blind placebo-controlled study. Am J Hosp Palliat Care. 2012;29(3):177\u201382.","journal-title":"Am J Hosp Palliat Care"},{"issue":"1","key":"1906_CR71","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jpainsymman.2007.02.043","volume":"35","author":"AL Kautio","year":"2008","unstructured":"Kautio AL, Haanp\u00e4\u00e4 M, Saarto T, Kalso E. Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms. J Pain Symptom Manag. 2008;35(1):31\u20139.","journal-title":"J Pain Symptom Manag"},{"issue":"4","key":"1906_CR72","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1136\/emj.2009.076596","volume":"28","author":"C G\u00fcloglu","year":"2011","unstructured":"G\u00fcloglu C, Orak M, Ust\u00fcndag M, Altunci YA. Analysis of amitriptyline overdose in emergency medicine. Emerg Med J. 2011;28(4):296\u20139.","journal-title":"Emerg Med J"},{"issue":"6","key":"1906_CR73","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/sj.bjp.0707253","volume":"151","author":"PK Gillman","year":"2007","unstructured":"Gillman PK. Tricyclic antidepressant pharmacology and therapeutic drug interactions updated. Br J Pharmacol. 2007;151(6):737\u201348.","journal-title":"Br J Pharmacol"},{"key":"1906_CR74","doi-asserted-by":"crossref","unstructured":"Larsen ER, Damkier P, Pedersen LH, Fenger-Gron J, Mikkelsen RL, Nielsen RE, Linde VJ, Knudsen HE, Skaarup L, Videbech P; Danish Psychiatric Society; Danish Society of Obstetrics and Gynecology; Danish Paediatric Society; Danish Society of Clinical Pharmacology. Use of psychotropic drugs during pregnancy and breast-feeding. Acta Psychiatr Scand Suppl. 2015;445:1\u201328.","DOI":"10.1111\/acps.12479"},{"issue":"3","key":"1906_CR75","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1097\/AOG.0b013e3181ba0632","volume":"114","author":"KA Yonkers","year":"2009","unstructured":"Yonkers KA, Wisner KL, Stewart DE, et\u00a0al. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Obstet Gynecol. 2009;114(3):703\u201313.","journal-title":"Obstet Gynecol"},{"key":"1906_CR76","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.coph.2005.11.003","volume":"6","author":"GJ Sills","year":"2006","unstructured":"Sills GJ. The mechanisms of action of gabapentin and pregabalin. Curr Opin Pharmacol. 2006;6:108\u201313.","journal-title":"Curr Opin Pharmacol"},{"key":"1906_CR77","doi-asserted-by":"publisher","first-page":"685","DOI":"10.2165\/00023210-200620080-00010","volume":"20","author":"JE Frampton","year":"2006","unstructured":"Frampton JE, Foster RH. Pregabalin: in the treatment of generalised anxiety disorder. CNS Drugs. 2006;20:685\u201393.","journal-title":"CNS Drugs"},{"issue":"5","key":"1906_CR78","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1001\/jamainternmed.2020.0249","volume":"180","author":"RF Anton","year":"2020","unstructured":"Anton RF, Latham P, Voronin K, Book S, Hoffman M, Prisciandaro J, Bristol E. Efficacy of gabapentin for the treatment of alcohol use disorder in patients with alcohol withdrawal symptoms: a randomized clinical trial. JAMA Intern Med. 2020;180(5):728\u201336.","journal-title":"JAMA Intern Med"},{"issue":"3","key":"1906_CR79","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/s41380-021-01386-6","volume":"27","author":"JSW Hong","year":"2022","unstructured":"Hong JSW, Atkinson LZ, Al-Juffali N, Awad A, Geddes JR, Tunbridge EM, Harrison PJ, Cipriani A. Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: systematic review, meta-analysis, and rationale. Mol Psychiatry. 2022;27(3):1339\u201349.","journal-title":"Mol Psychiatry"},{"issue":"9","key":"1906_CR80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003322","volume":"17","author":"E Patorno","year":"2020","unstructured":"Patorno E, Hernandez-Diaz S, Huybrechts KF, Desai RJ, Cohen JM, Mogun H, Bateman BT. Gabapentin in pregnancy and the risk of adverse neonatal and maternal outcomes: a population-based cohort study nested in the US Medicaid Analytic eXtract dataset. PLoS Med. 2020;17(9): e1003322.","journal-title":"PLoS Med"},{"key":"1906_CR81","doi-asserted-by":"crossref","unstructured":"DeLisle A, Jones HE, Jansson LM. Gabapentin use during pregnancy and lactation with and without concurrent opioid exposure: considerations and future directions. J Addict Med. 2022;17:123\u20135.","DOI":"10.1097\/ADM.0000000000001065"},{"key":"1906_CR82","doi-asserted-by":"crossref","unstructured":"Andrade C. Safety of pregabalin in pregnancy. J Clin Psychiatry. 2018;79(5):18f12568.","DOI":"10.4088\/JCP.18f12568"},{"issue":"10","key":"1906_CR83","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2165\/11536200-000000000-00000","volume":"49","author":"HN Bockbrader","year":"2010","unstructured":"Bockbrader HN, Wesche D, Miller R, Chapel S, Janiczek N, Burger P. A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin Pharmacokinet. 2010;49(10):661\u20139.","journal-title":"Clin Pharmacokinet"},{"key":"1906_CR84","doi-asserted-by":"crossref","unstructured":"Wiffen PJ, Derry S, Moore RA, Kalso EA. Carbamazepine for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2014;2014(4):CD005451.","DOI":"10.1002\/14651858.CD005451.pub3"},{"key":"1906_CR85","doi-asserted-by":"crossref","unstructured":"Fricke-Galindo I, LLerena A, Jung-Cook H, L\u00f3pez-L\u00f3pez M. Carbamazepine adverse drug reactions. Expert Rev Clin Pharmacol. 2018;11(7):705\u201318.","DOI":"10.1080\/17512433.2018.1486707"},{"key":"1906_CR86","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.eplepsyres.2016.02.013","volume":"122","author":"I Kacirova","year":"2016","unstructured":"Kacirova I, Grundmann M, Brozmanova H. Concentrations of carbamazepine and carbamazepine-10,11-epoxide in maternal and umbilical cord blood at birth: Influence of co-administration of valproic acid or enzyme-inducing antiepileptic drugs. Epilepsy Res. 2016;122:84\u201390.","journal-title":"Epilepsy Res"},{"issue":"1","key":"1906_CR87","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/bja\/aet208","volume":"111","author":"MT Fallon","year":"2013","unstructured":"Fallon MT. Neuropathic pain in cancer. Br J Anaesth. 2013;111(1):105\u201311.","journal-title":"Br J Anaesth"},{"issue":"4","key":"1906_CR88","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1093\/bja\/aer260","volume":"107","author":"P Anand","year":"2011","unstructured":"Anand P, Bley K. Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch. Br J Anaesth. 2011;107(4):490\u2013502.","journal-title":"Br J Anaesth"},{"key":"1906_CR89","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1586\/ern.10.182","volume":"11","author":"M Wallace","year":"2011","unstructured":"Wallace M, Pappagallo M. Qutenza(R): a capsaicin 8% patch for the management of postherpetic neuralgia. Expert Rev Neurother. 2011;11:15\u201327.","journal-title":"Expert Rev Neurother"},{"issue":"3","key":"1906_CR90","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1533-2500.2011.00485.x","volume":"12","author":"A Vadalouca","year":"2012","unstructured":"Vadalouca A, Raptis E, Moka E, Zis P, Sykioti P, Siafaka I. Pharmacological treatment of neuropathic cancer pain: a comprehensive review of the current literature. Pain Pract. 2012;12(3):219\u201351.","journal-title":"Pain Pract"},{"issue":"5","key":"1906_CR91","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/jps.10133","volume":"91","author":"BJ Campbell","year":"2002","unstructured":"Campbell BJ, Rowbotham M, Davies PS, Jacob P 3rd, Benowitz NL. Systemic absorption of topical lidocaine in normal volunteers, patients with post-herpetic neuralgia, and patients with acute herpes zoster. J Pharm Sci. 2002;91(5):1343\u201350.","journal-title":"J Pharm Sci"},{"key":"1906_CR92","doi-asserted-by":"crossref","unstructured":"Lunn MP, Hughes RA, Wiffen PJ. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev. 2014;(1):CD007115.","DOI":"10.1002\/14651858.CD007115.pub3"},{"issue":"1","key":"1906_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jcpt.12216","volume":"40","author":"LA VanderWeide","year":"2015","unstructured":"VanderWeide LA, Smith SM, Trinkley KE. A systematic review of the efficacy of venlafaxine for the treatment of fibromyalgia. J Clin Pharm Ther. 2015;40(1):1\u20136.","journal-title":"J Clin Pharm Ther"},{"key":"1906_CR94","doi-asserted-by":"crossref","unstructured":"Cooper TE, Derry S, Wiffen PJ, Moore RA. Gabapentin for fibromyalgia pain in adults. Cochrane Database Syst Rev. 2017;1(1):CD012188.","DOI":"10.1002\/14651858.CD012188"},{"issue":"1","key":"1906_CR95","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s40199-019-00257-4","volume":"27","author":"A Bidari","year":"2019","unstructured":"Bidari A, Moazen-Zadeh E, Ghavidel-Parsa B, Rahmani S, Hosseini S, Hassankhani A. Comparing duloxetine and pregabalin for treatment of pain and depression in women with fibromyalgia: an open-label randomized clinical trial. Daru. 2019;27(1):149\u201358.","journal-title":"Daru"},{"issue":"6","key":"1906_CR96","first-page":"697","volume":"19","author":"RE Heymann","year":"2001","unstructured":"Heymann RE, Helfenstein M, Feldman D. A double-blind, randomized, controlled study of amitriptyline, nortriptyline and placebo in patients with fibromyalgia. An analysis of outcome measures. Clin Exp Rheumatol. 2001;19(6):697\u2013702.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"1906_CR97","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/art.20076","volume":"51","author":"JK Tofferi","year":"2004","unstructured":"Tofferi JK, Jackson JL, O\u2019Malley PG. Treatment of fibromyalgia with cyclobenzaprine: a meta-analysis. Arthritis Rheum. 2004;51(1):9\u201313.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"1906_CR98","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.3109\/14767058.2013.850663","volume":"27","author":"A Moreira","year":"2014","unstructured":"Moreira A, Barbin C, Martinez H, Aly A, Fonseca R. Maternal use of cyclobenzaprine (Flexeril) may induce ductal closure and persistent pulmonary hypertension in neonates. J Matern Fetal Neonatal Med. 2014;27(11):1177\u20139.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"3","key":"1906_CR99","first-page":"365","volume":"78","author":"S See","year":"2008","unstructured":"See S, Ginzburg R. Choosing a skeletal muscle relaxant. Am Fam Physician. 2008;78(3):365\u201370.","journal-title":"Am Fam Physician"}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-023-01906-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40265-023-01906-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-023-01906-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T15:23:46Z","timestamp":1689953026000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40265-023-01906-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,22]]},"references-count":99,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1906"],"URL":"https:\/\/doi.org\/10.1007\/s40265-023-01906-4","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,22]]},"assertion":[{"value":"5 June 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding was received for the preparation of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"IZ, RM, and MS declare that they have no conflicts of interest that might be relevant to the contents of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}},{"value":"IZ, RM, and MS contributed to the conception and design of the paper. IZ led the literature retrieval and review with support from RM and MS. IZ and RM led the writing of the paper with oversight and critical review by MS. MS led the reviewer response and final revisions with support from IZ and RM.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}},{"value":"Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}}]}}